These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 15700135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions.
    Wada T, Onogi Y, Kimura Y, Nakano T, Fusanobori H, Ishii Y, Sasahara M, Tsuneki H, Sasaoka T.
    Eur J Pharmacol; 2013 May 05; 707(1-3):120-9. PubMed ID: 23528355
    [Abstract] [Full Text] [Related]

  • 4. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
    Ferry G, Tellier E, Try A, Grés S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, Chomarat P, Dieu M, Raes M, Galizzi JP, Valet P, Boutin JA, Saulnier-Blache JS.
    J Biol Chem; 2003 May 16; 278(20):18162-9. PubMed ID: 12642576
    [Abstract] [Full Text] [Related]

  • 5. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
    Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attané C, Wanecq E, Guigné C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I.
    Am J Physiol Endocrinol Metab; 2010 Jun 16; 298(6):E1161-9. PubMed ID: 20233941
    [Abstract] [Full Text] [Related]

  • 6. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S, Adachi S, Manabe E, Mizushima K, Hattori T, Okuda T, Nakabe N, Handa O, Takagi T, Naito Y, Yoshida N, Yoshikawa T.
    Int J Hyperthermia; 2007 May 16; 23(3):259-65. PubMed ID: 17523018
    [Abstract] [Full Text] [Related]

  • 7. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size.
    Takahashi M, Kamei Y, Ezaki O.
    Am J Physiol Endocrinol Metab; 2005 Jan 16; 288(1):E117-24. PubMed ID: 15353408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS, Lee JJ, Kim Y, Kim IS, Zhang WY, Myung CS.
    Arch Pharm Res; 2011 Apr 16; 34(4):615-24. PubMed ID: 21544727
    [Abstract] [Full Text] [Related]

  • 11. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids.
    D'Eon TM, Pierce KA, Roix JJ, Tyler A, Chen H, Teixeira SR.
    Diabetes; 2008 May 16; 57(5):1262-8. PubMed ID: 18276766
    [Abstract] [Full Text] [Related]

  • 12. Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance.
    Arai C, Arai N, Mizote A, Kohno K, Iwaki K, Hanaya T, Arai S, Ushio S, Fukuda S.
    Nutr Res; 2010 Dec 16; 30(12):840-8. PubMed ID: 21147367
    [Abstract] [Full Text] [Related]

  • 13. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY, Choi YH, Lee W.
    J Ethnopharmacol; 2008 Feb 12; 115(3):473-82. PubMed ID: 18068920
    [Abstract] [Full Text] [Related]

  • 14. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C, Dusaulcy R, Tréguer K, Grès S, Attané C, Saulnier-Blache JS.
    Biochimie; 2014 Jan 12; 96():140-3. PubMed ID: 23639740
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
    Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA.
    Oncogene; 2004 Mar 25; 23(13):2357-66. PubMed ID: 14691447
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice.
    Caton PW, Kieswich J, Yaqoob MM, Holness MJ, Sugden MC.
    Diabetes Obes Metab; 2011 Dec 25; 13(12):1097-104. PubMed ID: 21733059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.